2,966 reports of this reaction
4.3% of all DONEPEZIL HYDROCHLORIDE reports
#1 most reported adverse reaction
FALL is the #1 most commonly reported adverse reaction for DONEPEZIL HYDROCHLORIDE, manufactured by Camber Pharmaceuticals, Inc.. There are 2,966 FDA adverse event reports linking DONEPEZIL HYDROCHLORIDE to FALL. This represents approximately 4.3% of all 69,498 adverse event reports for this drug.
Patients taking DONEPEZIL HYDROCHLORIDE who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is moderately reported among DONEPEZIL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to fall, the following adverse reactions have been reported for DONEPEZIL HYDROCHLORIDE:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 2,966 FDA reports for DONEPEZIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 4.3% of all adverse event reports for DONEPEZIL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience fall while taking DONEPEZIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.